Millennium Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Sell
2,700
-13,100
-83% -$2.55M ﹤0.01% 4740
2025
Q4
$2.74M Buy
15,800
+13,800
+690% +$2.51M ﹤0.01% 3659
2025
Q3
$381K Buy
2,000
+400
+25% +$71K ﹤0.01% 5230
2025
Q2
$287K Sell
1,600
-9,800
-86% -$1.7M ﹤0.01% 5216
2025
Q1
$1.93M Sell
11,400
-30,200
-73% -$4.96M ﹤0.01% 3815
2024
Q4
$6.28M Buy
41,600
+36,700
+749% +$5.71M ﹤0.01% 2620
2024
Q3
$761K Sell
4,900
-165,100
-97% -$24.7M ﹤0.01% 4486
2024
Q2
$23.3M Sell
170,000
-245,700
-59% -$33.6M 0.01% 1362
2024
Q1
$55.3M Sell
415,700
-117,900
-22% -$15.3M 0.02% 763
2023
Q4
$73.6M Buy
533,600
+283,600
+113% +$37.3M 0.03% 559
2023
Q3
$30.5M Buy
250,000
+225,000
+900% +$30M 0.02% 1075
2023
Q2
$3.51M Buy
+25,000
New +$3.45M ﹤0.01% 2981
2023
Q1
Sell
-10,000
Closed -$1.56M 6461
2022
Q4
$1.56M Sell
10,000
-60,000
-86% -$8.62M ﹤0.01% 3763
2022
Q3
$8.59M Buy
70,000
+20,000
+40% +$2.63M 0.01% 2333
2022
Q2
$6.65M Buy
+50,000
New +$6.81M ﹤0.01% 2497
2022
Q1
Sell
-70,000
Closed -$12.1M 7005
2021
Q4
$12.1M Sell
70,000
-60,000
-46% -$9.13M 0.01% 1933
2021
Q3
$18.9M Buy
130,000
+29,100
+29% +$4.26M 0.01% 1385
2021
Q2
$13.3M Buy
100,900
+40,900
+68% +$5.35M 0.01% 1571
2021
Q1
$7.7M Buy
60,000
+40,000
+200% +$4.93M 0.01% 2082
2020
Q4
$2.38M Buy
20,000
+10,000
+100% +$1.22M ﹤0.01% 3104
2020
Q3
$1.15K Sell
10,000
-20,000
-67% -$2.36M ﹤0.01% 3044
2020
Q2
$3.42M Buy
+30,000
New +$3.18M ﹤0.01% 2109
2019
Q2
Sell
-210,000
Closed -$18.9M 4112
2019
Q1
$18.9M Buy
+210,000
New +$18.2M 0.03% 837
2018
Q1
Sell
-10,000
Closed -$985K 3710
2017
Q4
$985K Buy
+10,000
New +$948K ﹤0.01% 2711
2013
Q4
Sell
-38,800
Closed -$2.4M 3506
2013
Q3
$2.4M Buy
+38,800
New +$2.32M 0.01% 1569

Other funds holding DGX

Millennium Management's DGX Position: Q1 2026 in Review

Millennium Management increased its Quest Diagnostics (DGX) stake by 3.6% in Q1 2026, buying an estimated $340K and bringing the position to 50,166 shares worth $9.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2183.

Millennium Management first reported a position in DGX in Q2 2013 and has held it in 47 quarters since. The position peaked at $130M in Q2 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Millennium Management held 50,166 shares of Quest Diagnostics worth $9.83M as of Q1 2026.
  • Millennium Management bought 1,750 Quest Diagnostics shares in Q1 2026, an estimated $340K.
  • Quest Diagnostics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2183 holding.
  • Millennium Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 47 quarters since.
  • Millennium Management's Quest Diagnostics position peaked at $130M in Q2 2024.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.